1. Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke 1 
Martin K Childers, DO, PhD, Allison Brashear, MD, Patricia Jozefczyk, MD, Michael Reding, MD, David Alexander, MD, David Good, MD, Jennifer M Walcott, MS, S.W Jenkins, MD, Catherine Turkel, PharmD, Patricia T Molloy, MD 
Archives of Physical Medicine and Rehabilitation 
Volume 85, Issue 7, Pages (July 2004)
DOI: /j.apmr

2. Fig 1
Participant flow, interventions, and efficacy measurements. ∗Efficacy measures after the first treatment cycle included: MAS scores (wrist, elbow, fingers), physician and patient global assessments, pain assessment, FIM, and SF-36. †Efficacy measures after the second treatment cycle included: MAS scores (wrist) and global assessments.
Archives of Physical Medicine and Rehabilitation  , DOI: ( /j.apmr )

3. Fig 2
Change in MAS scores at the wrist in subjects with excessive muscle tone after a stroke. NOTE. Data are mean values. Negative scores are clinically desirable.
Archives of Physical Medicine and Rehabilitation  , DOI: ( /j.apmr )

4. Fig 3
Change in MAS scores at the elbow in subjects with excessive muscle tone after a stroke. NOTE. Data are mean values. Negative scores are clinically desirable.
Archives of Physical Medicine and Rehabilitation  , DOI: ( /j.apmr )